[Antihypoxic activity of the novel intraorganoid pharmacological preparation mitochondrin].
The antihypoxant and membranoprotector properties of the new intraorganoid pharmacological preparation mitochondrin (M-1) were studied in two series of experiments. In the first series, the drug activity was studied on a model of hypoxia with hypercapny; in the second series, the drug was tested on a model of hemic hypoxia caused by neurotoxic damage (acute nitrobenzene intoxication). It was established that M-1 (obtained from the brain tissue of newborn rabbits) possesses antihypoxant activity, which is manifested in both hypoxia--hypercapnia and hemic hypoxia. The drug effect was more pronounced 3 h after administration than on the next day. The antihypoxant action of M-1 is related to the cytomembrane neuroprotector activity.